Variant report
Variant | nsv967190 |
---|---|
Chromosome Location | chr3:162932772-162983278 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:41)
- CpG islands (count:0)
- Chromatin interactive region (count:5)
- LncRNA region (count:15)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
(count:41 , 50 per page) page:
1
No. | Transcrition factor | Chromosome Location | Cell Line | Cell type | Cell Stage | Matched TF binding sites |
---|---|---|---|---|---|---|
1 | CEBPB | chr3:162978995-162979027 | K562 | blood: | n/a | n/a |
2 | CHD2 | chr3:162976142-162976148 | H1-hESC | embryonic stem cell: | n/a | n/a |
3 | CTCF | chr3:162953064-162953107 | Spleen_OC | spleen: | n/a | n/a |
4 | CTCF | chr3:162973547-162973685 | Medullo | brain: | n/a | chr3:162973613-162973621 chr3:162973609-162973625 chr3:162973610-162973631 |
5 | CTCF | chr3:162946522-162946561 | GM20000 | blood: | n/a | n/a |
6 | CTCF | chr3:162968471-162968556 | GM20000 | blood: | n/a | n/a |
7 | EBF1 | chr3:162975133-162975166 | GM12878 | blood: | n/a | n/a |
8 | EBF1 | chr3:162978952-162979124 | GM12878 | blood: | n/a | chr3:162979034-162979045 |
9 | ELK1 | chr3:162935493-162935499 | Hela-S3 | cervix: | n/a | n/a |
10 | FOXA2 | chr3:162954989-162955392 | A549 | lung: | n/a | n/a |
11 | FOXA2 | chr3:162954899-162955485 | A549 | lung: | n/a | n/a |
12 | GATA3 | chr3:162965902-162966184 | SH-SY5Y | brain: | n/a | n/a |
13 | GATA3 | chr3:162946554-162946752 | SH-SY5Y | brain: | n/a | n/a |
14 | IRF1 | chr3:162978801-162978908 | K562 | blood: | n/a | n/a |
15 | JUN | chr3:162939168-162939270 | H1-hESC | embryonic stem cell: | n/a | n/a |
16 | MAFK | chr3:162950725-162950744 | H1-hESC | embryonic stem cell: | n/a | n/a |
17 | MAFK | chr3:162945809-162945821 | K562 | blood: | n/a | chr3:162945810-162945821 |
18 | MYC | chr3:162974907-162974908 | MCF10A-Er-Src | breast: | n/a | n/a |
19 | MYC | chr3:162963651-162963897 | MCF10A-Er-Src | breast: | n/a | n/a |
20 | POLR2A | chr3:162980793-162980992 | MCF10A-Er-Src | breast: | n/a | n/a |
21 | POLR2A | chr3:162942403-162942588 | MCF10A-Er-Src | breast: | n/a | n/a |
22 | POLR2A | chr3:162973714-162973755 | MCF10A-Er-Src | breast: | n/a | n/a |
23 | POLR2A | chr3:162960831-162960922 | Hela-S3 | cervix: | n/a | n/a |
24 | POLR2A | chr3:162975099-162975279 | MCF10A-Er-Src | breast: | n/a | n/a |
25 | POLR2A | chr3:162964060-162964153 | MCF10A-Er-Src | breast: | n/a | n/a |
26 | POLR2A | chr3:162951394-162951539 | MCF10A-Er-Src | breast: | n/a | n/a |
27 | POLR2A | chr3:162974567-162974728 | MCF10A-Er-Src | breast: | n/a | n/a |
28 | POLR2A | chr3:162960907-162961287 | MCF10A-Er-Src | breast: | n/a | n/a |
29 | POLR2A | chr3:162941014-162941115 | MCF10A-Er-Src | breast: | n/a | n/a |
30 | POLR2A | chr3:162963425-162963830 | MCF10A-Er-Src | breast: | n/a | n/a |
31 | POLR2A | chr3:162942982-162943122 | MCF10A-Er-Src | breast: | n/a | n/a |
32 | POLR2A | chr3:162981441-162981525 | MCF10A-Er-Src | breast: | n/a | n/a |
33 | RAD21 | chr3:162973481-162973768 | Hela-S3 | cervix: | n/a | chr3:162973609-162973628 |
34 | RCOR1 | chr3:162974716-162974730 | GM12878 | blood: | n/a | n/a |
35 | REST | chr3:162966169-162966363 | Hela-S3 | cervix: | n/a | chr3:162966282-162966302 chr3:162966282-162966302 |
36 | REST | chr3:162966086-162966488 | HL-60 | blood: | n/a | chr3:162966282-162966302 chr3:162966282-162966302 |
37 | REST | chr3:162966121-162966521 | PANC-1 | pancreas: | n/a | chr3:162966282-162966302 chr3:162966282-162966302 |
38 | REST | chr3:162966127-162966428 | MCF-7 | breast: | n/a | chr3:162966282-162966302 chr3:162966282-162966302 |
39 | REST | chr3:162966087-162966490 | ECC-1 | luminal epithelium: | n/a | chr3:162966282-162966302 chr3:162966282-162966302 |
40 | RFX5 | chr3:162973564-162973693 | Hela-S3 | cervix: | n/a | n/a |
41 | STAT3 | chr3:162978775-162978822 | MCF10A-Er-Src | breast: | n/a | n/a |
No data |
(count:5 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr3:162973215..162973789-chr3:163207913..163208691,2 | MCF-7 | breast: | |
2 | chr3:162965564..162967593-chr3:162971986..162973917,2 | K562 | blood: | |
3 | chr10:69265595..69266499-chr3:162973315..162973821,2 | MCF-7 | breast: | |
4 | chr3:162965564..162967593-chr3:162971986..162973917,2 | K562 | blood: | |
5 | chr3:162924888..162927929-chr3:162929573..162933579,3 | K562 | blood: |
(count:15 , 50 per page) page:
1
No. | lncRNA name | Chromosome Location | lncRNA alias |
---|---|---|---|
1 | lnc-SI-4 | chr3:162937889-162937975 | ENSG00000241369 |
2 | lnc-OTOL1-2 | chr3:162948497-162949937 | ENSG00000241168.1 |
3 | lnc-SI-4 | chr3:162937889-162937975 | ENSG00000241369 |
4 | lnc-OTOL1-2 | chr3:162937866-162937980 | NONHSAT093026 |
5 | lnc-SI-4 | chr3:162967053-162967162 | ENSG00000241369 |
6 | lnc-OTOL1-2 | chr3:162948497-162949934 | NONHSAT093026 |
7 | lnc-SI-4 | chr3:162937704-162937975 | ENSG00000241369 |
8 | lnc-OTOL1-2 | chr3:162946486-162946540 | NONHSAT093026 |
9 | lnc-OTOL1-2 | chr3:162946486-162946540 | ENSG00000241168.1 |
10 | lnc-SI-4 | chr3:162937889-162937929 | ENSG00000241369 |
11 | lnc-SI-4 | chr3:162937889-162937975 | ENSG00000241369 |
12 | lnc-OTOL1-2 | chr3:162937866-162937980 | ENSG00000241168.1 |
13 | lnc-SI-4 | chr3:162937889-162937975 | ENSG00000241369 |
14 | lnc-SI-4 | chr3:162937889-162937975 | ENSG00000241369 |
15 | lnc-SI-4 | chr3:162936848-162936965 | ENSG00000241369 |
No data |
No data |
Variant related genes | Relation type |
---|---|
CT64 | TF binding region |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs534014284 | chr3:162936401-162936402 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
2 | rs149438677 | chr3:162936453-162936454 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
3 | rs146400163 | chr3:162936546-162936547 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
4 | rs542251513 | chr3:162936592-162936593 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
5 | rs556136506 | chr3:162936654-162936655 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
6 | rs539462579 | chr3:162936666-162936667 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
7 | rs551020434 | chr3:162936774-162936775 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
8 | rs576615515 | chr3:162936810-162936811 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
9 | rs551332414 | chr3:162936834-162936835 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
10 | rs139058463 | chr3:162936837-162936838 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
11 | rs4538378 | chr3:162936850-162936851 | Weak transcription | lncRNA | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
12 | rs541273521 | chr3:162936949-162936950 | Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
13 | rs142362307 | chr3:162936963-162936964 | Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
14 | rs375696173 | chr3:162936997-162936998 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
15 | rs117586221 | chr3:162937066-162937067 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
16 | rs548667406 | chr3:162937077-162937078 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
17 | rs189467046 | chr3:162937094-162937095 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
18 | rs367744093 | chr3:162937113-162937114 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
19 | rs563724239 | chr3:162937120-162937121 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs531472622 | chr3:162937123-162937124 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs376905191 | chr3:162937186-162937187 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs397769679 | chr3:162937192-162937193 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs200967832 | chr3:162937193-162937194 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs202132338 | chr3:162937194-162937195 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs200340183 | chr3:162937195-162937196 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs551687165 | chr3:162937226-162937227 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs571595275 | chr3:162937309-162937310 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs139658848 | chr3:162937397-162937398 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs376095787 | chr3:162937467-162937468 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs5854028 | chr3:162937497-162937498 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs371842621 | chr3:162937498-162937499 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs533975386 | chr3:162937531-162937532 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs371577372 | chr3:162937583-162937584 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs548113803 | chr3:162937598-162937599 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs536351839 | chr3:162937610-162937611 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs555849272 | chr3:162937629-162937630 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs11374574 | chr3:162937679-162937680 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs575973346 | chr3:162937688-162937689 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs373174528 | chr3:162937689-162937690 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs182048325 | chr3:162937698-162937699 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs558820623 | chr3:162937715-162937716 | Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
42 | rs572445511 | chr3:162937734-162937735 | Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
43 | rs185014956 | chr3:162937826-162937827 | Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
44 | rs561149340 | chr3:162937835-162937836 | Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
45 | rs4021822 | chr3:162937939-162937940 | Weak transcription | lncRNA | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
46 | rs543913302 | chr3:162938044-162938045 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs142157298 | chr3:162938050-162938051 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs532517116 | chr3:162938051-162938052 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs190652475 | chr3:162938110-162938111 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs534797287 | chr3:162938159-162938160 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Basal cell lymphoma | 17053054 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Uveal melanoma | 21693616 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Retinoblastoma | 21504564 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Intellectual disability | 22102821 | CNVD |
Autism | 22495311 | CNVD |
Lung cancer | 18438408 | CNVD |
Squamous cell cancer | 20885788 | CNVD |
Melanoma | 18172304 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Breast cancer | 22032731 | CNVD |
Breast cancer | 16461572 | CNVD |
Neuroblastoma | 17533364 | CNVD |
Cervical Cancer | 21857958 | CNVD |
Melanoma | 21693616 | CNVD |
Lung cancer | 21426551 | CNVD |
Cancer | 21637783 | CNVD |
Cervical cancer | 21063398 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Liposarcoma | 21253554 | CNVD |
Oral cancer | 21386901 | CNVD |
Renal cell carcinoma | 19461508 | CNVD |
Cancer | 22065749 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Basal cell lymphoma | 21115979 | CNVD |
head and neck squamous cell carcinoma | 17671120 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
Myelodysplastic syndrome | 21251322 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Acute lymphoblastic leukemia | 21339820 | CNVD |
Breast cancer | 16608533 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Non-small cell lung cancer | 19010865 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Ovarian clear cell carcinoma | 21343371 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Prostate cancer | 16547154 | CNVD |
Breast cancer | 21364760 | CNVD |
Gastrointestinal stromal cancer | 20818650 | CNVD |
Prostate cancer | 16573809 | CNVD |
Breast cancer | 21785460 | CNVD |
Sudden cardiac death | 19188705 | CNVD |
Mantle cell lymphoma | 19029149 | CNVD |
Malformation | 19546859 | CNVD |
Schizophrenia | 19546859 | CNVD |
Breast cancer | 17133270 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Hirschsprung''s Disease | 21712996 | CNVD |
Attention deficit hyperactivity disorder | 21324949 | CNVD |
Barrett''s adenocarcinoma | 18663352 | CNVD |
epilepsy | 18472482 | CNVD |
Myeloproliferative neoplasm | 20015882 | CNVD |
Myxofibrosarcoma | 16751306 | CNVD |
Parkinson disease | 21907011 | CNVD |
Bladder cancer | 21909424 | CNVD |
Non-syndromic sensorineural hearing loss | 17122850 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr3:162936400-162950200 | Weak transcription | HUES6 Cell Line | embryonic stem cell |
2 | chr3:162947400-162954200 | Weak transcription | ES-I3 Cell Line | embryonic stem cell |
3 | chr3:162953800-162954800 | Enhancers | iPS-15b Cell Line | embryonic stem cell |
4 | chr3:162954200-162954800 | Active TSS | ES-I3 Cell Line | embryonic stem cell |
5 | chr3:162954200-162954800 | Active TSS | ES-WA7 Cell Line | embryonic stem cell |
6 | chr3:162975800-162976200 | Enhancers | ES-I3 Cell Line | embryonic stem cell |